Overview
In partnership with the Foundation for Innovative New Diagnostics (FIND), IRD Global implemented a community-based integrated TB–NCD screening program in Dhaka, Bangladesh and Metro Manila, Philippines from June to October 2023.
The project aimed to address the growing co-burden of tuberculosis (TB), diabetes (DM), and hypertension (HTN) through a unified screening, referral, and counseling model targeting vulnerable adult populations (18+).
Screening was conducted in public health facilities, community outreach camps and urban and peri-urban settlements.
The program leveraged IRD’s WellCheck platform, digital data collection via Hydra, strong collaboration with National TB and NCD programs, and integrated mental health counseling to ensure comprehensive, patient-centered care In Bangladesh, 42,107 individuals were approached and 37,458 screened, with implementation balanced between facilities (46%) and communities (54%). In Metro Manila, 24,093 individuals were screened, with 97% of implementation conducted in community settings. The model prioritized women, elderly populations, and vulnerable urban communities.
61,551
individuals screened for TB, diabetes and hypertension
598
individuals newly diagnosed with hypertension
360
individuals newly diagnosed with diabetes
158
individuals newly diagnosed with TB
Our Partners
- Foundation for Innovative New Diagnostics (FIND)
- National TB Control Programs
- Government NCD Corners
- Public health facilities in Bangladesh and the Philippines
- Community leaders and local stakeholders
The Need
The Need
Our Approach: Delivery
1. Integrated Community & Facility Screening
Between Bangladesh and the Philippines:
- 61,551 individuals screened
- 158 new TB cases detected
- 360 new diabetes cases diagnosed
- 598 new hypertension cases diagnosed
In Bangladesh alone:
- 37,458 individuals screened
- 150 TB cases diagnosed (100% treatment initiation ensured)
- 358 diabetes cases confirmed
- 563 hypertension cases confirmed
Screening included:
- Verbal TB symptom screening
- GeneXpert referral for presumptive TB
- Glucometer-based blood sugar testing
- Digital blood pressure monitoring
- Referral to government NCD corners and TB facilities
Strong government collaboration enabled high confirmatory testing uptake and treatment initiation.
2. Digital Monitoring through Hydra
All data were captured via IRD’s Hydra mobile platform, enabling:
- Real-time screening and referral tracking
- Secure, encrypted data management
- Performance dashboards for supervisors
- Rapid workflow adjustments
- Offline data entry with cloud synchronization
Hydra ensured accountability across the screening-to-treatment cascade and improved follow-up of presumptive cases.
3. Addressing Co-Morbidity
The project generated important data on disease overlap:
- TB + Diabetes
- TB + Hypertension
- Diabetes + Hypertension (~5% prevalence)
- TB + DM + HTN (rare but clinically significant)
Notably:
- 18% of TB patients had diabetes
- 25.6% of TB patients had hypertension
These findings underscore the importance of integrated screening
rather than siloed disease programs.
4. Mental Health Integration
Mental health screening was embedded within the TB–NCD pathway.
- 579 patients screened for depression/anxiety
- 44% showed symptoms
- 97.7% enrolled in counseling
- 100% of those completing sessions experienced remission of symptoms
Lay counselors delivered structured sessions using validated tools
(PHQ-4, PHQ-9, GAD-7), demonstrating that task-shifted mental health
services are feasible and effective in low-resource settings.
Our partners
PDI has a nationwide footprint, focusing on districts identified by the national STH survey— 47 at-risk districts requiring annual deworming.



